Feb 14 (Reuters)-
Solasia Pharma K. K.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2022 Dec 31, 2021 Dec 31, 2023 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 1.09 559 mln
(+95.5 pct) (+23.1 pct)
Operating loss 1.70 loss 2.21
Recurring loss 1.77 loss 2.23
Net loss 2.08 loss 2.23
EPS loss 13.72 yen loss 17.15 yen
EPS Diluted loss 13.72 yen loss 17.15 yen
NOTE - Solasia Pharma K. K..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4597.T